@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://www.w3.org/ns/prov#> .
@prefix this: <http://purl.org/np/RAh84I4tGQwlcHmzw7IPKKEISYfLk377Vm7Aetdn7KXxU> .
@prefix sub: <http://purl.org/np/RAh84I4tGQwlcHmzw7IPKKEISYfLk377Vm7Aetdn7KXxU#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_9993> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_9993> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB00040> ;
    a rdf:Statement ;
    rdfs:label "for the treatment of severe hypoglycemia glucagon is indicated as a treatment for severe hypoglycemia low blood sugar which may occur in patients with diabetes mellitus because patients with type 1 diabetes may have less of an increase in blood glucose levels compared with a stable type 2 patient supplementary carbohydrate should be given as soon as possible especially to a pediatric patient for use as a diagnostic aid glucagon is indicated as a diagnostic aid in the radiologic examination of the stomach duodenum small bowel and colon when diminished intestinal motility would be advantageous glucagon is as effective for this examination as are the anticholinergic drugs however as use of glucagon in combination with anticholinergic drugs may result in increased side effects the use of glucagon in combination with anticholinergic drugs is not recommended" ;
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation schema:TreatmentIndication .
  <https://identifiers.org/drugbank:DB00040> bl:category bl:Drug .
}
sub:provenance {
  sub:assertion ns1:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
    npx:hasSignature "LR2f3quyhlBbx+HxyZ9hXdpmBWaOBk312m6MlhB/EhRJvuitlGjuGTMau3VbKSNF6Be7BsZ9G8SF3q5XUKlhelJbxb3d7g13un/QI83HPAThvI17V9AlE18bupqBY6LrnGA5CoaSSHZHrlxN41auhOzX5K70GAZpndhIdF9atfw=" ;
    npx:hasSignatureTarget this: .
  this: dcterms:created "2021-07-03T12:29:44.639+02:00"^^xsd:dateTime ;
    dcterms:creator orcid:0000-0002-1468-3557 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}